Zhejiang Orient Gene Biotech Co Ltd (688298) — Free Cash Flow Generation Index

Latest as of September 2022: 0.61x

Zhejiang Orient Gene Biotech Co Ltd (688298) has a Free Cash Flow Generation Index of 0.61x as of September 2022. Free cash flow of CN¥190.31 Million represents 1% of operating cash flow (CN¥309.89 Million). Read Zhejiang Orient Gene Biotech Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.61x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥190.31 Million
CNY

Operating Cash Flow

CN¥309.89 Million
CNY

Capital Expenditures

CN¥119.58 Million
CNY

Zhejiang Orient Gene Biotech Co Ltd Free Cash Flow Generation Index (2016–2022)

Historical FCF Generation Index trend for Zhejiang Orient Gene Biotech Co Ltd across 7 annual periods. Explore Zhejiang Orient Gene Biotech Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Zhejiang Orient Gene Biotech Co Ltd (2016–2022)

Year-by-year Free Cash Flow Generation Index for Zhejiang Orient Gene Biotech Co Ltd. For the full company profile including market capitalisation, see Zhejiang Orient Gene Biotech Co Ltd market capitalisation.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2022 0.65x CN¥1.94 Billion CN¥3.00 Billion CN¥1.05 Billion ▼ -28.1%
2021 0.90x CN¥4.70 Billion CN¥5.20 Billion CN¥507.87 Million ▼ -2.9%
2020 0.93x CN¥1.66 Billion CN¥1.79 Billion CN¥126.93 Million ▲ +19.0%
2019 0.78x CN¥42.31 Million CN¥54.21 Million CN¥11.90 Million ▲ +35.9%
2018 0.57x CN¥25.45 Million CN¥44.33 Million CN¥18.88 Million ▼ -4.5%
2017 0.60x CN¥20.16 Million CN¥33.54 Million CN¥13.38 Million ▼ -0.8%
2016 0.61x CN¥7.16 Million CN¥11.81 Million CN¥4.65 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).